Replies to post #479 on Cynapsus Therapeutics Inc. (CYNA)

[noretreat]

I have learned to never simply dismiss the potential competitor. In my view, being first to approval matters as much as delivery method, as long as both are "relatively" easy. The inhaler is slated for 2017. I strongly feel that it is important for Cynapsus to be there first.